342 related articles for article (PubMed ID: 26961686)
1. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.
Vaupel P; Multhoff G
Strahlenther Onkol; 2016 May; 192(5):279-87. PubMed ID: 26961686
[TBL] [Abstract][Full Text] [Related]
2. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
Silva-Vilches C; Ring S; Mahnke K
Front Immunol; 2018; 9():2581. PubMed ID: 30473700
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression.
Vaupel P; Mayer A
Adv Exp Med Biol; 2016; 876():177-183. PubMed ID: 26782210
[TBL] [Abstract][Full Text] [Related]
4. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
[TBL] [Abstract][Full Text] [Related]
5. A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation.
Morandi F; Morandi B; Horenstein AL; Chillemi A; Quarona V; Zaccarello G; Carrega P; Ferlazzo G; Mingari MC; Moretta L; Pistoia V; Malavasi F
Oncotarget; 2015 Sep; 6(28):25602-18. PubMed ID: 26329660
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
7. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
[TBL] [Abstract][Full Text] [Related]
8. The CD73/Ado System-A New Player in RT Induced Adverse Late Effects.
de Leve S; Wirsdörfer F; Jendrossek V
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623231
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy.
de Leve S; Wirsdörfer F; Jendrossek V
Front Immunol; 2019; 10():698. PubMed ID: 31024543
[TBL] [Abstract][Full Text] [Related]
10. Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.
He T; Brocca-Cofano E; Gillespie DG; Xu C; Stock JL; Ma D; Policicchio BB; Raehtz KD; Rinaldo CR; Apetrei C; Jackson EK; Macatangay BJ; Pandrea I
J Virol; 2015 Sep; 89(18):9616-30. PubMed ID: 26178986
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
de Andrade Mello P; Coutinho-Silva R; Savio LEB
Front Immunol; 2017; 8():1526. PubMed ID: 29184552
[TBL] [Abstract][Full Text] [Related]
12. Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
Kumar V
Purinergic Signal; 2013 Jun; 9(2):145-65. PubMed ID: 23271562
[TBL] [Abstract][Full Text] [Related]
13. The yin and yang functions of extracellular ATP and adenosine in tumor immunity.
Feng LL; Cai YQ; Zhu MC; Xing LJ; Wang X
Cancer Cell Int; 2020; 20():110. PubMed ID: 32280302
[TBL] [Abstract][Full Text] [Related]
14. The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.
Da M; Chen L; Enk A; Ring S; Mahnke K
Front Immunol; 2022; 13():914799. PubMed ID: 35711418
[TBL] [Abstract][Full Text] [Related]
15. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations.
Morandi F; Horenstein AL; Quarona V; Faini AC; Castella B; Srinivasan RC; Strom SC; Malavasi F; Gramignoli R
J Immunol; 2019 Feb; 202(3):724-735. PubMed ID: 30587530
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2018; 1072():171-175. PubMed ID: 30178341
[TBL] [Abstract][Full Text] [Related]
18. Calcium Phosphate-Reinforced Metal-Organic Frameworks Regulate Adenosine-Mediated Immunosuppression.
Liang L; Yang LL; Wang W; Ji C; Zhang L; Jia Y; Chen Y; Wang X; Tan J; Sun ZJ; Yuan Q; Tan W
Adv Mater; 2021 Nov; 33(45):e2102271. PubMed ID: 34554618
[TBL] [Abstract][Full Text] [Related]
19. A(1) and A(3) adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes.
Gessi S; Merighi S; Stefanelli A; Fazzi D; Varani K; Borea PA
Pharmacol Res; 2013 Oct; 76():157-70. PubMed ID: 23969284
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive activities of adenosine in cancer.
Allard B; Beavis PA; Darcy PK; Stagg J
Curr Opin Pharmacol; 2016 Aug; 29():7-16. PubMed ID: 27209048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
